Gaël Champier
Chief Executive Officer at B Cell Design SAS
Profile
Gaël Champier founded B Cell Design SAS, where they worked as Chief Executive Officer.
Dr. Champier also currently works at ArkAb SAS, as Chief Executive Officer & Director from 2018.
Dr. Champier received their graduate degree from Université de Limoges.
Gaël Champier active positions
| Companies | Position | Start |
|---|---|---|
B Cell Design SAS
 B Cell Design SAS Miscellaneous Commercial ServicesCommercial Services B Cell Design SAS provides pharmaceutical services. It offers research and development services in producing antibodies. The firm serves as a platform for other diagnostic and pharmaceutical companies addressed to academic laboratories and industrial research. The company was founded in December 7, 2007 and is headquartered in Limoges, France. | Chief Executive Officer | - |
ArkAb SAS
 ArkAb SAS Medical SpecialtiesHealth Technology Part of Inoviem Scientific SAS, ArkAb SAS develops, manufactures, and commercializes raw materials for research in immunology and in vitro diagnostic market. The private company is based in Limoges, France. The French company was founded in 2018. The CEO is Gaël Champier. | Chief Executive Officer | 2018-01-12 |
Training of Gaël Champier
| Université de Limoges | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 2 |
|---|---|
B Cell Design SAS
B Cell Design SAS Miscellaneous Commercial ServicesCommercial Services B Cell Design SAS provides pharmaceutical services. It offers research and development services in producing antibodies. The firm serves as a platform for other diagnostic and pharmaceutical companies addressed to academic laboratories and industrial research. The company was founded in December 7, 2007 and is headquartered in Limoges, France. | Commercial Services |
ArkAb SAS
ArkAb SAS Medical SpecialtiesHealth Technology Part of Inoviem Scientific SAS, ArkAb SAS develops, manufactures, and commercializes raw materials for research in immunology and in vitro diagnostic market. The private company is based in Limoges, France. The French company was founded in 2018. The CEO is Gaël Champier. | Health Technology |
- Stock Market
- Insiders
- Gaël Champier
